Copper-64 SAR Bombesin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Copper-64 SAR Bombesin, covering 2023-09-26 to 2023-09-26. Get the full timeline:
Most recent: Clinical Trial Update: Copper-64 SAR Bombesin in PSMA Negative Prostate Cancer (BOP) [Phase 2]